In-vitro assessment of anti-breast cancer potential of pumpkin seed oil nanoemulsion with mechanistic insights into cytotoxicity and apoptosis
Abstract
Breast cancer is the most prevalent malignancy in women with 16% of all cancer deaths and current therapies frequently resulting in significant adverse consequences. Pumpkin seed oil (PSO) possesses antibacterial, antiviral, cytotoxic, and anticancer effects. Nonetheless, its hydrophobic characteristics restrict bioavailability, which can be enhanced by a nanoemulsion system. The optimization of pumpkin seed oil nanoemulsion (PSO-NE) was affected by surfactant concentration and sonication duration, resulting in a droplet size of 152.0 nm, PDI of 0.189 and Zeta Potential of − 23.5 mV. PSO-NE displayed dose-dependent cytotoxicity, revealing a significantly decreased IC 50 compared to free PSO and Doxorubicin after 24 h of exposure (p < 0.01). At IC 50 concentration (MCF-7 = 46.6 μg/ml and MDA-MB-231 = 60 μg/ml) PSO-NE significantly elicited morphological alterations, decreased cell proliferation, enhanced phosphatidylserine exposure, and halted the cell cycle (p < 0.001). The expression of genes (Bcl-2, STAT-3, and NF-kB), associated with cell proliferation, was significantly downregulated (p < 0.001), while the expression of genes (p53, Bax, and caspase 3), linked to apoptosis, was significantly upregulated compared to the untreated cell lines (p < 0.001), indicating the activation of apoptotic gene expression. The targeted cytotoxicity of PSO-NE against breast cancer and its ability to induce apoptosis and cell cycle arrest, underscores a promising anticancer drug.
Read the paper
Related studies
- Treatment of non-metastatic castration-resistant prostate cancer: facing age-related comorbidities and drug–drug interactions
- The Efficacy of Flogofilm® in the Treatment of Chronic Bacterial Prostatitis as an Adjuvant to Antibiotic Therapy: A Randomized Prospective Trial
- Inhibition of growth and contraction in human prostate stromal cells by silencing of NUAK1 and -2, and by the presumed NUAK inhibitors HTH01-015 and WZ4003
- Effectiveness and Safety of a New Nutrient Fixed Combination Containing Pollen Extract Plus Teupolioside, in the Management of LUTS in Patients with Benign Prostatic Hypertrophy: A Pilot Study
- Extract from Cucurbita pepo improves BPH symptoms without affecting sexual function: a 24-month noninterventional study
- Aquablation vs. holmium laser enucleation of the prostate for benign prostatic hyperplasia: a 150-patients prospective comparative multicenter study
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.